Friday, September 01, 2017 9:00:51 PM
But it is a very bad choice. And there are other sources of credit. I believe that this is a potential company killer.
If they don't borrow any money from the CD then no problem.
But if they do borrow what ever amount they get is translated into common stock at a nice discount to the market price.
Surely, the lender would like to get the best return on their loan. That means getting more shares than less in the conversion process. So they accomplish that by shorting the stock to force the market share price lower. Then when the "conversion" takes place they get a whole bunch more shares than they would have otherwise.
The key issue is the shorting of the stock following the payment of the money and prior to the conversion. Normally, to short a stock you have to "borrow" shares in advance to cover the short. But a working CD serves just as well because shares will be forthcoming soon after the short is put on.
I know I am "preaching to the choir" here. You know very well what king of irreversible damage a Convertible Debenture can bring to a company that does not have the re3sources to defend the stock. Maybe Isodiol will use the $20M to buy back their own shares after they go sub-penny. Anything is possible.
I have been investing almost exclusively in penny stocks since the early 1970's. I have seen a lot of companies destroyed by the "death spiral" of share price that results from a CD. I have learned to avoid CD's like Ebola. I have only been a shareholder here for two weeks. Now that this CD is in place I am looking for a quick exit. There are tons of opportunities in MJ penny stocks that don't have a CD.
Good Luck.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM